메뉴 건너뛰기




Volumn 87, Issue 1, 2012, Pages 67-76

My treatment approach to hairy cell leukemia

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIINFECTIVE AGENT; B RAF KINASE; BENDAMUSTINE; CLADRIBINE; HEMOPOIETIC GROWTH FACTOR; IMMUNOTOXIN; INTERFERON; PENTOSTATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VEMURAFENIB;

EID: 84855699822     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2011.09.001     Document Type: Article
Times cited : (41)

References (46)
  • 1
    • 0015230817 scopus 로고
    • Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis
    • Yam LT, Li CY, Lam KW. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med. 1971;284(7):357-360.
    • (1971) N Engl J Med , vol.284 , Issue.7 , pp. 357-360
    • Yam, L.T.1    Li, C.Y.2    Lam, K.W.3
  • 2
    • 79959293462 scopus 로고    scopus 로고
    • BRAF mutations in hairy-cell leukemia
    • Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305-2315.
    • (2011) N Engl J Med , vol.364 , Issue.24 , pp. 2305-2315
    • Tiacci, E.1    Trifonov, V.2    Schiavoni, G.3
  • 3
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507-2516.
    • (2011) N Engl J Med , vol.364 , Issue.26 , pp. 2507-2516
    • Chapman, P.B.1    Hauschild, A.2    Robert, C.3
  • 4
    • 77950398474 scopus 로고    scopus 로고
    • Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine
    • Sigal DS, Sharpe R, Burian C, Saven A. Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood. 2010;115(10):1893-1896.
    • (2010) Blood , vol.115 , Issue.10 , pp. 1893-1896
    • Sigal, D.S.1    Sharpe, R.2    Burian, C.3    Saven, A.4
  • 5
    • 0020693431 scopus 로고
    • Response to splenectomy in 65 patients with hairy cell leukemia: An evaluation of spleen weight and bone marrow involvement
    • Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983;61(2):349-352. (Pubitemid 13137656)
    • (1983) Blood , vol.61 , Issue.2 , pp. 349-352
    • Golomb, H.M.1    Vardiman, J.W.2
  • 6
    • 0022217573 scopus 로고
    • Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients
    • DOI 10.1002/1097-0142(19851201)56:11<2557::AID-CNCR2820561103>3.0. CO;2-T
    • Magee MJ, McKenzie S, Filippa DA, Arlin ZA, Gee TS, Clarkson BD. Hairy cell leukemia: durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Cancer. 1985;56(11):2557-2562. (Pubitemid 16249913)
    • (1985) Cancer , vol.56 , Issue.11 , pp. 2557-2562
    • Magee, M.J.1    McKenzie, S.2    Filippa, D.A.3
  • 7
    • 0021345092 scopus 로고
    • Alpha interferon for induction of remission in hairy-cell leukemia
    • Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med. 1984;310(1):15-18. (Pubitemid 14212475)
    • (1984) New England Journal of Medicine , vol.310 , Issue.1 , pp. 15-18
    • Quesada, J.R.1    Reuben, J.2    Manning, J.T.3
  • 8
    • 0022525650 scopus 로고
    • Treatment of hairy cell leukemia with recombinant alpha-interferon
    • Quesada JR, Hersh EM, Manning J, et al. Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood. 1986;68(2):493-497. (Pubitemid 16050674)
    • (1986) Blood , vol.68 , Issue.2 , pp. 493-497
    • Quesada, J.R.1    Hersh, E.M.2    Manning, J.3
  • 9
    • 0028929938 scopus 로고
    • Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An Intergroup study
    • Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an Intergroup study. J Clin Oncol. 1995;13(4):974-982.
    • (1995) J Clin Oncol , vol.13 , Issue.4 , pp. 974-982
    • Grever, M.1    Kopecky, K.2    Foucar, M.K.3
  • 10
    • 0021681936 scopus 로고
    • Hairy-cell leukemia: Induction of complete remission with pentostatin (2'-deoxycoformycin)
    • Spiers AS, Parekh SJ, Bishop MB. Hairy-cell leukemia: induction of complete remission with pentostatin (2′-deoxycoformycin). J Clin Oncol. 1984;2(12):1336-1342. (Pubitemid 15179534)
    • (1984) Journal of Clinical Oncology , vol.2 , Issue.12 , pp. 1336-1342
    • Spiers, A.S.D.1    Parekh, S.J.2    Bishop, M.B.3
  • 11
    • 0024590995 scopus 로고
    • Pentostatin in the treatment of advanced hairy cell leukemia
    • Kraut EH, Bouroncle BA, Grever MR. Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol. 1989;7(2):168-172. (Pubitemid 19048448)
    • (1989) Journal of Clinical Oncology , vol.7 , Issue.2 , pp. 168-172
    • Kraut, E.H.1    Bouroncle, A.2    Grever, M.R.3
  • 12
    • 0025274664 scopus 로고
    • Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine
    • Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med. 1990;322(16):1117-1121. (Pubitemid 20149529)
    • (1990) New England Journal of Medicine , vol.322 , Issue.16 , pp. 1117-1121
    • Piro, L.D.1    Carrera, C.J.2    Carson, D.A.3    Beutler, E.4
  • 13
    • 0032530684 scopus 로고    scopus 로고
    • Long-term follow-up of patients with hairy cell leukemia after cladribine treatment
    • Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood. 1998;92(6):1918- 1926. (Pubitemid 28446680)
    • (1998) Blood , vol.92 , Issue.6 , pp. 1918-1926
    • Saven, A.1    Burian, C.2    Koziol, J.A.3    Piro, L.D.4
  • 14
    • 0037362951 scopus 로고    scopus 로고
    • Extended follow-up of patients with hairy cell leukemia after treatment with cladribine
    • DOI 10.1200/JCO.2003.05.093
    • Goodman GR, Burian C, Koziol JA, Saven A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol. 2003;21(5):891-896. (Pubitemid 46606450)
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.5 , pp. 891-896
    • Goodman, G.R.1    Burian, C.2    Koziol, J.A.3    Saven, A.4
  • 15
    • 22044444135 scopus 로고    scopus 로고
    • Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): Long-term follow-up of the Northwestern University experience
    • DOI 10.1182/blood-2005-01-0173
    • Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106(1):241-246. (Pubitemid 40967199)
    • (2005) Blood , vol.106 , Issue.1 , pp. 241-246
    • Chadha, P.1    Rademaker, A.W.2    Mendiratta, P.3    Kim, B.4    Evanchuk, D.M.5    Hakimian, D.6    Peterson, L.C.7    Tallman, M.S.8
  • 16
    • 4444288930 scopus 로고    scopus 로고
    • An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine
    • DOI 10.1038/sj.leu.2403418
    • Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia. 2004;18(9):1476-1481. (Pubitemid 39264069)
    • (2004) Leukemia , vol.18 , Issue.9 , pp. 1476-1481
    • Jehn, U.W.1    Bartl, R.2    Dietzfelbinger, H.3    Haferlach, T.4    Heinemann, V.5
  • 17
    • 0028925970 scopus 로고
    • Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia
    • Juliusson G, Heldal D, Hippe E, et al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol. 1995;13(4):989-995.
    • (1995) J Clin Oncol , vol.13 , Issue.4 , pp. 989-995
    • Juliusson, G.1    Heldal, D.2    Hippe, E.3
  • 19
    • 0031016704 scopus 로고    scopus 로고
    • Weekly administration of 2-chlorodeoxyadenosine in patients with hairy- cell leukemia: A new treatment schedule effective and safer in preventing infectious complications [5]
    • Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Blood. 1997;89(5):1838-1839. (Pubitemid 27097485)
    • (1997) Blood , vol.89 , Issue.5 , pp. 1838-1839
    • Lauria, F.1    Bocchia, M.2    Marotta, G.3    Raspadori, D.4    Zinzani, P.5    Rondelli, D.6
  • 20
    • 0032858782 scopus 로고    scopus 로고
    • Weekly administration of 2-chlorodeoxyadenosine in patients with hairy- cell leukemia is effective and reduces infectious complications
    • Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Haematologica. 1999;84(1):22-25. (Pubitemid 29479379)
    • (1999) Haematologica , vol.84 , Issue.1 , pp. 22-25
    • Lauria, F.1    Bocchia, M.2    Marotta, G.3    Raspadori, D.4    Zinzani, P.L.5    Rondelli, D.6
  • 23
    • 77950396626 scopus 로고    scopus 로고
    • Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: A multicenter phase III trial (SAKK 32/98)
    • Zenhausern R, Schmitz SF, Solenthaler M, et al. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leuk Lymphoma. 2009;50(9):1501-1511.
    • (2009) Leuk Lymphoma , vol.50 , Issue.9 , pp. 1501-1511
    • Zenhausern, R.1    Schmitz, S.F.2    Solenthaler, M.3
  • 24
    • 85047332993 scopus 로고    scopus 로고
    • Analysis of toxicity and efficacy of subcutaneous cladribine at reduced or standard doses (five versus seven consecutive days) in patients with hairy cell leukemia (HCL) in the ICGHCL2004 Protocol by the Italian Cooperative Group on HCL
    • ASH abstract 701
    • Forconi F, Cencini E, Zaja F, et al. Analysis of toxicity and efficacy of subcutaneous cladribine at reduced or standard doses (five versus seven consecutive days) in patients with hairy cell leukemia (HCL) in the ICGHCL2004 Protocol by the Italian Cooperative Group on HCL [ASH abstract 701]. Blood. 2010;116.
    • (2010) Blood , pp. 116
    • Forconi, F.1    Cencini, E.2    Zaja, F.3
  • 25
    • 0026799508 scopus 로고
    • Cladribine (2-chlorodeoxyadenosine)
    • Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet. 1992;340(8825):952-956.
    • (1992) Lancet , vol.340 , Issue.8825 , pp. 952-956
    • Beutler, E.1
  • 26
    • 0027941692 scopus 로고
    • Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin
    • Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood. 1994;84(12):4061-4063.
    • (1994) Blood , vol.84 , Issue.12 , pp. 4061-4063
    • Kraut, E.H.1    Grever, M.R.2    Bouroncle, B.A.3
  • 27
    • 0032940595 scopus 로고    scopus 로고
    • Long term outcome of patients with hairy cell leukemia treated with pentostatin
    • DOI 10.1002/(SICI)1097-0142(19990101)85:1<65::AID-CNCR9>3.0.CO;2-B
    • Ribeiro P, Bouaffia F, Peaud PY, et al. Long term outcome of patients with hairy cell leukemia treated with pentostatin. Cancer. 1999;85(1):65-71. (Pubitemid 29031357)
    • (1999) Cancer , vol.85 , Issue.1 , pp. 65-71
    • Ribeiro, P.1    Bouaffia, F.2    Peaud, P.-Y.3    Blanc, M.4    Salles, B.5    Salles, G.6    Coiffier, B.7
  • 28
    • 0034329819 scopus 로고    scopus 로고
    • Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
    • Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000;96(9):2981-2986.
    • (2000) Blood , vol.96 , Issue.9 , pp. 2981-2986
    • Flinn, I.W.1    Kopecky, K.J.2    Foucar, M.K.3
  • 30
    • 0032842507 scopus 로고    scopus 로고
    • Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine
    • DOI 10.1046/j.1365-2141.1999.01546.x
    • Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. Br J Haematol. 1999;106(2):515-519. (Pubitemid 29450680)
    • (1999) British Journal of Haematology , vol.106 , Issue.2 , pp. 515-519
    • Dearden, C.E.1    Matutes, E.2    Hilditch, B.L.3    Swansbury, G.J.4    Catovsky, D.5
  • 31
    • 66749169284 scopus 로고    scopus 로고
    • Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
    • Else M, Dearden CE, Matutes E, et al. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol. 2009;145(6):733-740.
    • (2009) Br J Haematol , vol.145 , Issue.6 , pp. 733-740
    • Else, M.1    Dearden, C.E.2    Matutes, E.3
  • 32
    • 0042243678 scopus 로고    scopus 로고
    • Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia
    • DOI 10.1182/blood-2003-01-0014
    • Nieva J, Bethel K, Saven A. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood. 2003;102(3):810-813. (Pubitemid 36917768)
    • (2003) Blood , vol.102 , Issue.3 , pp. 810-813
    • Nieva, J.1    Bethel, K.2    Saven, A.3
  • 33
    • 0035669026 scopus 로고    scopus 로고
    • Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    • DOI 10.1046/j.1365-2141.2001.03143.x
    • Hagberg H, Lundholm L. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol. 2001;115(3):609-611. (Pubitemid 34015651)
    • (2001) British Journal of Haematology , vol.115 , Issue.3 , pp. 609-611
    • Hagberg, H.1    Lundholm, L.2
  • 34
    • 50849088318 scopus 로고    scopus 로고
    • Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)
    • Zenhausern R, Simcock M, Gratwohl A, Hess U, Bargetzi M, Tobler A. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica. 2008;93(9):1426-1428.
    • (2008) Haematologica , vol.93 , Issue.9 , pp. 1426-1428
    • Zenhausern, R.1    Simcock, M.2    Gratwohl, A.3    Hess, U.4    Bargetzi, M.5    Tobler, A.6
  • 37
    • 79961229946 scopus 로고    scopus 로고
    • Phase II study of sequential therapy with cladribine followed by an extended course rituximab in patients with hairy cell leukemia
    • ASH abstract 2458
    • Ravandi F, Jorgensen J, O'Brien S, et al. Phase II study of sequential therapy with cladribine followed by an extended course rituximab in patients with hairy cell leukemia [ASH abstract 2458]. Blood. 2010;116.
    • (2010) Blood , pp. 116
    • Ravandi, F.1    Jorgensen, J.2    O'Brien, S.3
  • 38
    • 52649089106 scopus 로고    scopus 로고
    • Rituximab as treatment for minimal residual disease in hairy cell leukaemia: Extended follow-up
    • Cervetti G, Galimberti S, Andreazzoli F, et al. Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up. Br J Haematol. 2008;143(2):296-298.
    • (2008) Br J Haematol , vol.143 , Issue.2 , pp. 296-298
    • Cervetti, G.1    Galimberti, S.2    Andreazzoli, F.3
  • 39
    • 79957474897 scopus 로고    scopus 로고
    • Rituximab with pentostatin or cladribine: An effective combination treatment for hairy cell leukemia after disease recurrence
    • Else M, Dearden CE, Matutes E, et al. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leuk Lymphoma. 2011;52(suppl 2):75-78.
    • (2011) Leuk Lymphoma , vol.52 , Issue.SUPPL. 2 , pp. 75-78
    • Else, M.1    Dearden, C.E.2    Matutes, E.3
  • 40
    • 0033561067 scopus 로고    scopus 로고
    • Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia
    • Saven A, Burian C, Adusumalli J, Koziol JA. Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia. Blood. 1999;93(8):2471-2477. (Pubitemid 29181177)
    • (1999) Blood , vol.93 , Issue.8 , pp. 2471-2477
    • Saven, A.1    Burian, C.2    Adusumalli, J.3    Koziol, J.A.4
  • 42
    • 67649933809 scopus 로고    scopus 로고
    • Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia
    • Kreitman RJ, Stetler-Stevenson M, Margulies I, et al. Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol. 2009;27(18):2983-2990.
    • (2009) J Clin Oncol , vol.27 , Issue.18 , pp. 2983-2990
    • Kreitman, R.J.1    Stetler-Stevenson, M.2    Margulies, I.3
  • 43
    • 80051743261 scopus 로고    scopus 로고
    • A phase 1 study of moxetumomab pasudotox, an anti-CD22 recombinant immunotoxin, in relapsed/refractory hairy cell leukemia (HCL): Updated results
    • ASH abstract 2516
    • Kreitman RJ, Tallman MS, Coutre S, et al. A phase 1 study of moxetumomab pasudotox, an anti-CD22 recombinant immunotoxin, in relapsed/refractory hairy cell leukemia (HCL): updated results [ASH abstract 2516]. Blood. 2010;116.
    • (2010) Blood , pp. 116
    • Kreitman, R.J.1    Tallman, M.S.2    Coutre, S.3
  • 44
    • 5444223561 scopus 로고    scopus 로고
    • Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment [1]
    • DOI 10.1038/sj.thj.6200373
    • Fietz T, Rieger K, Schmittel A, Thiel E, Knauf W. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment. Hematol J. 2004;5(5):451-452. (Pubitemid 39359285)
    • (2004) Hematology Journal , vol.5 , Issue.5 , pp. 451-452
    • Fietz, T.1    Rieger, K.2    Schmittel, A.3    Thiel, E.4    Knauf, W.5
  • 46
    • 0001322730 scopus 로고
    • Leukemic reticuloendotheliosis
    • Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609-630.
    • (1958) Blood , vol.13 , Issue.7 , pp. 609-630
    • Bouroncle, B.A.1    Wiseman, B.K.2    Doan, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.